USPTO serial 79339266
EXELIOM BIOSCIENCES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 20, 2023
- Examiner
- BUTLER, MIDGE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EXELIOM BIOSCIENCES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew Roppel
Andrew Roppel Holland & Hart LLPPO Box 8749Attn. Trademark DocketingDenver, CO 80201Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for the treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; natural medicines for the treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; isotopes for medical use; yeast for medical, veterinary or pharmaceutical use; microbicides, namely, germicides for the prevention and treatment of immune-mediated diseases and infectious diseases; chemical preparations for medical use, namely, chemical preparations for the prevention and treatment of immune-mediated diseases and infectious diseases; biochemical preparations for medical purposes, namely, biochemical preparations for the prevention and treatment of immune-mediated diseases and infectious diseases; bacteriological preparations for medical use, namely, bacteriological preparations for the prevention and treatment of immune-mediated diseases and infectious diseases; biological preparations for medical use, namely, biological preparations for the prevention and treatment of immune-mediated diseases and infectious diseases; mixed biological preparations for medical use, namely, mixed biological preparations for the prevention and treatment of the immune-mediated diseases and infectious diseases; preparations of trace elements for human and animal consumption, namely, nutritional supplements, vitamins and dietetic beverages for the prevention and treatment of immune-mediated diseases and infectious diseases; preparations for enemas; nucleic acid sequences for medical and veterinary use; vaccines; vaccines for human use; blood substitutes for human use; beverages for babies, namely, infant formula, powdered milk for babies, baby food in beverage form, and nutritionally fortified beverages for medical purposes; mother's milk substitutes; drug delivery release agents in the nature of tablet coatings which facilitate the release of nutritional supplements; dietetic foods for clinical nutrition for medical purposes; dietetic foods adapted for medical purposes for sick people; dietetic foods for medical use; dietetic food adapted for diabetics; antioxidants; dietetic beverages for medical use; food supplements; protein supplement shakes; fruit juice beverages for diabetics, adapted for medical purposes; enzyme food supplements; protein food supplements; food supplements for controlling cholesterol; food supplements for infants; food supplements suitable for human consumption; food supplement with cosmetic effect; dietary supplements for persons with special diets; probiotic supplements; prebiotic supplements; dietetic confectionery products for medical use, namely, medicated candies for the prevention and treatment of intestinal omeothesis; dietary fibers, namely, dietary fiber for the prevention and treatment of intestinal omeothesis; beverage mixtures used as food supplements; slimming pills; freeze-dried food for medical use; medicinal drinks; vitamin and mineral products, namely, vitamin and mineral preparations for the prevention and treatment of immune-mediated diseases and infectious diseases; dietetic foods adapted for medical use; dietetic preparations adapted for medical purposes; nutraceutical preparations for therapeutic or medical use, namely, nutraceuticals for the prevention and treatment of intestinal omeothesis; medicinal preparations used as additives for food intended for human consumption, namely, medicinal preparations for the prevention and treatment of intestinal omeothesis; multivitamin preparations; dietetic preparations for medical use; dietetic infusions for medical use; medicated food supplements; amino acids for pharmaceutical use; rubbing compounds for pharmaceutical use; milk ferments for pharmaceutical use; ferments for medical or veterinary use; ferments for pharmaceutical use; probiotic bacterial substances for medical use; medicinal herbs; medicines for the treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; plant-based medicines for the treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; medicated lozenges; lozenges for pharmaceutical use; anti-neoplastic preparations of microbial origin, namely, pharmaceutical preparations for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; plant preparations for medical use, namely, plant preparations for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; bacteriological preparations for pharmaceutical use; biotechnological preparations for medical use; chemical-pharmaceutical preparations; chemical preparations for pharmaceutical use; pharmaceutical preparations for human use; probiotic preparations for medical use to help maintain a natural balance of the intestinal flora in the digestive system; chemical products for pharmaceutical use, namely, chemical preparations for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; pharmaceutical products, namely, pharmaceutical preparations for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; injectable pharmaceutical products, namely, injectable pharmaceutical preparations for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; purgatives; medicinal preparations and substances, namely, drug delivery agents for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; mineral preparations and antibacterial substances for medical use; pharmaceutical preparations and substances, namely, pharmaceutical products for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; preparations of microorganisms for medical and veterinary use; biological reagents for medical use; chemical reagents for medical use; diagnostic reagents for medical use; chemical analysis reagents for medical use; reagents for microbiological analysis for medical use; regents for medical diagnosis; reagents for diagnostic tests for medical use; nutritive substances for microorganism cultures | ACTIVE | — |
| 035 | Compilation of scientific information into computer databases | ACTIVE | — |
| 042 | Scientific and technological research services in the field of medicine; medical and pharmacological research services; laboratory analysis in the field of bacteriology; scientific research and analysis in the field of medicine; design and development of medical technologies; technical advice with respect to technical research in the field of food and beverages; technical advice with respect to research services concerning food and food supplements; development of new products; research laboratory services in the field of pharmaceuticals; providing scientific research services; providing information and results relating to scientific research from an online searchable database; preparation of reports concerning scientific research; preparation of scientific reports; research for new products for others; product research for others; chemical technology research; research and development in the field of biotechnology; research and development of new products; research and development of new products for third parties; scientific and industrial research in the field of medicine; product research for others in the field of food products; research for developing new products; industrial analysis and research services in the field of chemistry; assessment of the effectiveness of industrial chemical products; consultant services in the field of scientific research; providing advisory information services in the field of scientific instruments; advice relating to scientific research; providing advice in connection with medical science; professional advice relating to food technology; technical consultancy with respect to product development; development of medicines; development and testing of chemical production methods; scientific laboratory services | ACTIVE | — |
| 044 | Health care services for human beings; pharmaceutical advice, namely, providing medical information services; advice in the field of dietetics and nutrition; health counseling services; information regarding health; provision of information relating to dietary and nutritional supplements; provision of information relating to dietary and nutritional recommendation services; providing information regarding food supplements and nutrition; preparing medical reports relating to health care, namely, providing medical information to patients; information and advisory services with respect to health; Advisory services relating to medical heath care; medical advisory services in dietetics; genetic testing on animals for diagnostic or treatment purposes; advisory and information services provided via the Internet with respect to development and research of pharmaceutical products; advisory and information services with respect to development and research of pharmaceutical products; advisory and information services with respect to development and research of biopharmaceutical products; information service relating to medicines; advisory services regarding the research and development of pharmaceutical products; information services concerning the research and development of pharmaceutical products; providing information relating to the preparation and dispensing of medicines; consultation with respect to pharmacy; pharmaceutical advice; advisory services with respect to nutrition; dietetic services; medical treatment of allergies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EXELIOM BIOSCIENCES
- Other trademarks owned by EXELIOM BIOSCIENCES
- Other trademarks owned by EXELIOM BIOSCIENCES
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named EXELIOM BIOSCIENCES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 16, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 25, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 25, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 20, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 20, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 20, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 4, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 4, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 15, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 27, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 27, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 27, 2023 | ALIE | ASSIGNED TO LIE | — |
| Feb 27, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 27, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 27, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 17, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 16, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 16, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 12, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 22, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 22, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 28, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 27, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 25, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| May 3, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 29, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 28, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |